THE POWER OF REVERSIBLE PROTEASOME INHIBITION Trademark

Trademark Overview


On Tuesday, May 20, 2008, a trademark application was filed for THE POWER OF REVERSIBLE PROTEASOME INHIBITION with the United States Patent and Trademark Office. The USPTO has given the THE POWER OF REVERSIBLE PROTEASOME INHIBITION trademark a serial number of 77478756. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2012. This trademark is owned by Millennium Pharmaceuticals, Inc.. The THE POWER OF REVERSIBLE PROTEASOME INHIBITION trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, oncologic diseases and disorders, excluding analgesics

research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; consultation services, namely, providing consultation to others via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology; providing on-line computer databases via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology

medical services and medical diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress
the power of reversible proteasome inhibition

General Information


Serial Number77478756
Word MarkTHE POWER OF REVERSIBLE PROTEASOME INHIBITION
Filing DateTuesday, May 20, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 30, 2008

Trademark Statements


Goods and Servicesprescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, oncologic diseases and disorders, excluding analgesics
Goods and Servicesresearch services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; consultation services, namely, providing consultation to others via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology; providing on-line computer databases via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology
Goods and Servicesmedical services and medical diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 23, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, May 23, 2008
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 23, 2008
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, January 23, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 23, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 16, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, June 15, 2011EXTENSION 5 GRANTED
Friday, June 10, 2011EXTENSION 5 FILED
Friday, June 10, 2011TEAS EXTENSION RECEIVED
Saturday, November 27, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, November 26, 2010EXTENSION 4 GRANTED
Tuesday, November 23, 2010EXTENSION 4 FILED
Tuesday, November 23, 2010TEAS EXTENSION RECEIVED
Thursday, June 10, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, June 9, 2010EXTENSION 3 GRANTED
Wednesday, June 2, 2010EXTENSION 3 FILED
Wednesday, June 2, 2010TEAS EXTENSION RECEIVED
Thursday, January 21, 2010EXTENSION 2 GRANTED
Friday, December 4, 2009EXTENSION 2 FILED
Thursday, January 21, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 4, 2009TEAS EXTENSION RECEIVED
Thursday, June 4, 2009EXTENSION 1 GRANTED
Thursday, June 4, 2009EXTENSION 1 FILED
Thursday, June 4, 2009TEAS EXTENSION RECEIVED
Tuesday, December 23, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 30, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 10, 2008NOTICE OF PUBLICATION
Tuesday, August 26, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 26, 2008ASSIGNED TO LIE
Saturday, August 16, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 15, 2008ASSIGNED TO EXAMINER
Friday, May 23, 2008NEW APPLICATION ENTERED IN TRAM